Justifying the high prevalence of microalbuminuria for type 2 diabetic patients in Taiwan with conditional probability approach-a DEMAND II Study

Journal of the Chinese Medical Association

Volumn 74, Issue 1, 2011, Pages 3-10

  Chiang, Shu Chiung ^a,b   Lee, Jenn Kuen ^c   Chen, Chih Hung ^d   Chuang, Lee Ming ^e   Tsan, Kun Wu ^f   Sheu, Wayne Huey Herng ^g   Wu, Du An ^h   Wu, Ta Jen ⁱ   Lin, Kwo Chuan ^j   Juang, Jyuhn Huarng ^k   Wang, Chih Yuan ^l   Ho, Low Tone ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f MACKAY MEMORIAL HOSPITAL   (Taiwan)

^g TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^h BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

ⁱ NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^j CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^k CHANG GUNG UNIVERSITY   (Taiwan)

^l FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

more..

Author keywords

Chronic kidney disease; Conditional probability; Microalbuminuria; Taiwan; Type 2 diabetes

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN; HEMOGLOBIN A1C; SERUM ALBUMIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; ESTIMATED GLOMERULUS FILTRATION RATE; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH CARE POLICY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROTEINURIA; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL; SCREENING TEST; SYSTOLIC BLOOD PRESSURE; TAIWAN; URINALYSIS; URINARY ALBUMIN TO CREATININE RATIO; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROBABILITY; RISK FACTORS; TAIWAN;

EID: 79551483296     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2011.01.001     Document Type: Article

References (21)

1. Parving H.H., Lehnert H., Bröchner-Mortensen J., Gomis R., Andersen S., Arner P. The effect of Irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001, 345:870-878.
2. Parving H.H., Lewis J.B., Ravid M., Remuzzi G., Hunsicker L.G. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 2006, 69:2057-2063. DEMAND Investigators.
3. American Diabetes Association Nephropathy in diabetes. Position statement. Diabetes Care 2004, 27(Suppl 1):S79-S83.
4. Guidelines for type 2 diabetes mellitus 2006, Chinese Taipei Diabetes Association (CTDA), Chinese Taipei Diabetes Association, Taipei.
5. Wu A.Y., Kong N.C., de Leon F.A., Pan C.Y., Tai T.Y., et al. An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia 2005, 48:17-26.
6. Lewis E.J., Hunsicker L.G., Clarke W.R., Berl T., Pohl M.A., Lewis J.B., et al. Renoprotective effect of the angiotensin receptor antagonist Irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001, 345:851-860.
7. Joint Institutional Review Board (JIRB). Accessed 2010. http://www.jirb.org.tw.
8. Watts G.F., Morris R.W., Khan K., Polak A. Urinary albumin excretion in healthy adult subjects: reference values and some factors affecting their interpretation. Clin Chim Acta 1988, 172:191-198.
9. Lu B., Song X., Dong X., Yang Y., Zhang Z., Wen J., et al. High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown. Diabetes Res Clin Pract 2007, 75:184-192.
10. Konta T., Hao Z., Abiko H., Ishikawa M., Takahashi T., Ikeda A., et al. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata Study. Kidney Int 2006, 70:751-775.
11. Yang W., Lu J., Weng J., Jia W., Ji L., Xiao J., et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010, 362:1090-1101.
12. Hsu C.C., Hwang S.J., Wen C.P., Chang H.Y., Chen T., Shiu R.S., et al. High prevalence and low awareness of CKD in Taiwan: a study on the relationship between serum creatinine and awareness from a nationally representative survey. Am J Kidney Dis 2006, 48:727-738.
13. Wen C.P., Cheng T.Y., Tsai M.K., Chang Y.C., Chan H.T., Tsai S.P., et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462293 adults in Taiwan. Lancet 2008, 371:2173-2182.
14. Lin C.H., Yang W.C., Tsai S.T., Tung T.H., Chou P. A community-based study of chronic kidney disease among type 2 diabetics in Kinmen, Taiwan. Diabetes Res Clin Pract 2007, 75:306-312.
15. Bakris G.L., Toto R.D., McCullough P.A., Rocha R., Purkayastha D., Davis P. Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD Study. Kidney Int 2008, 73:1303-1309. GUARD Study Investigators.
16. Arauz-Pacheco C., Parrott M.A., Raskin P. Hypertension management in adults with diabetes. Diabetes Care 2004, 27(Suppl 1):S65-S67. American Diabetes Association.
17. Buse J.B., Ginsberg H.N., Bakris G.L., Clark N.G., Costa F., Eckel R., et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 2007, 30:162-172.
18. Chen H.S., Wu T.E., Jap T.S., Lee S.H., Wang M.L., Lu R.A., et al. Decrease heart rate variability but preserve postural blood pressure change in type 2 diabetes with microalbuminuria. J Chin Med Assoc 2006, 69:254-258.
19. Zhao H.L., Thomas G.N., Leung W., Tomlinson B., Hsu Y.H., Chan P. An update on the management of nephropathy in type 2 diabetes. J Chin Med Assoc 2003, 66:627-636.
20. Hsu S.R., Lin S.D., Tu S.T., Liao P.Y., Su S.L., Lin S.L., et al. Metabolic control with insulin pump therapy: preliminary experience. J Chin Med Assoc 2008, 71:353-356.
21. Holman R.R., Paul S.K., Bethel M.A., Mathews D.R., Neil H.A. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008, 359:1577-1589.